Key result
Male gender was associated with similar rates of appropriate shock and mortality compared to female gender in patients with nonischemic cardiomyopathy.
Why the study?
Does gender affect the rate of appropriate shock and mortality in patients with nonischemic cardiomyopathy who have implantable cardioverter-defibrillators?
Cohort (n=140)
No
Does gender affect the rate of appropriate shock and mortality in patients with nonischemic cardiomyopathy who have implantable cardioverter-defibrillators?
Gender does not appear to be a significant risk factor for mortality or arrhythmic events in patients with nonischemic cardiomyopathy receiving ICDs.
Answers are grounded in this paper and cite their sources.
No gender difference in ICD outcomes supports uniform management; leaves open prospective validation in nonischemic cardiomyopathy.
BACKGROUND: As heart disease is increasingly recognized in women and as important studies have elucidated the benefit of implantable cardioverter defibrillators (ICDs) in patients with nonischemic cardiomyopathy (NICM), little is known regarding the effect of gender difference on arrhythmic risk in this population. We sought to determine if there are gender differences in arrhythmic risk and potential defibrillator benefit in patients with NICM. METHODS: The records of 767 consecutive patients who underwent ICD implant at the Stanford Medical Center from 1984 to 2002 were reviewed. Only patients with NICM were considered (n = 201, 26.2%). Of these, 140 patients had clinical follow-up information available. Baseline variables were examined, including age, baseline heart rate, ejection fraction, and medications. We evaluated the time to first shock as well as all-cause mortality in this patient population. Kaplan-Meier survival curves were plotted, a log-rank test was used to evaluate significance, and Cox-proportional hazards test was used for multivariate analysis. RESULTS: There were 88 (62.9%) men and 52 (37.1%) women. Between male and female patients, there were no significant differences in baseline mean age (54.8 +/- 1.9 years vs 53.1 +/- 2.3 years, respectively), ejection fraction (35.2 +/- 2.0% vs 33.3 +/- 2.3%, respectively), and mean left ventricular end-diastolic dimension (6.4 +/- 0.3 cm vs 5.9 +/- 0.2 cm, respectively). Mean follow-up time was 30.8 months. Thirty-two male patients (36.4 +/- 0.05%) received appropriate shocks compared with 20 female patients (38.5 +/- 0.07%). Mean time to the first appropriate shock was 11.9 +/- 3.9 months for male patients and 21.3 +/- 5.8 months for female patients (P = 0.2). Nineteen male patients (21.6 +/- 0.05%) died or received heart transplant during the follow-up period compared with 6 female patients (11.5 +/- 0.04%) (P = 0.11). CONCLUSION: Male and female patients with NICM who received ICDs had similar rate of appropriate shock and mortality. In this population gender does not appear to be an important risk factor for mortality or arrhythmic events.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2007) conducted a cohort in Nonischemic cardiomyopathy (n=140). Male gender vs. Female gender was evaluated on Appropriate shock (p=0.2). Male gender was associated with similar rates of appropriate shock and mortality compared to female gender in patients with nonischemic cardiomyopathy.
Synapse has enriched 10 related papers. Consider them for comparative context: